Probarbital
From Wikipedia, the free encyclopedia
 |
|
|
Probarbital
|
|
| Systematic (IUPAC) name | |
| 5-ethyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C9H14N2O3 |
| Mol. mass | 198.219 g/mol |
| Synonyms | Probarbital, Ipral, Vasalgin, 5-Isopropyl-5-ethylbarbituric acid |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Probarbital (trade names Ipral, Vasalgin) is a barbiturate derivative invented in the 1920s. It has sedative, hypnotic and anticonvulsant properties.
[edit] References
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||
